Prosecution Insights
Last updated: October 04, 2026

Mccarter & English, LLP

Technology areas: Biotechnology & Pharmaceuticals • Communications

177 pending office actions • 37 clients • 161 examiners • 92 art units • 25 of 177 (14%) have an AI response strategy ready • 8 patents granted in the last 365 days

Quality Metrics (n=9397 apps, methodology: how we score firms)

86.9%
Allowance Rate
n=9397
+0.45σ
Allowance Rate (norm)
n=9397
4.6
OAs to Allowance
n=7019
+0.64σ
OAs to Allow (norm)
n=7019
1255 days
Time to Allowance
n=7019
+6.9pp
Interview Lift
n=9397
37.2%
RCE Rate
n=9397
2.2%
Appeal Rate
n=9397

Rejection Performance (% of received rejections ultimately overcome)

88.0%
§101 Overcome
n=1825
84.7%
§102 Overcome
n=3295
86.2%
§103 Overcome
n=5383
88.1%
§112 Overcome
n=2882

Specialization & Scale

H04W, H04L, G06F
Top CPC Subclasses
35%
Top-3 CPC Share
n=9397
50
Practitioners
n=9397
187.9
Apps / Practitioner
n=9397

Portfolio Summary

177
Total Pending OAs
109
Non-Final OAs
60
Final Rejections
8
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 67 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

38
Overdue
1
Due this week
12
Due this month
9
Due in next 60 days
7
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 67 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (38)Due ≤ 7 days (1)Due ≤ 30 days (12)Due ≤ 60 days (9)Due later (7)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

66
Hard (37%)
99
Medium (56%)
11
Easy (6%)
1
Unknown (1%)

Rejection Statute Mix

BucketCases
§101 only6 (3%)
§101 + other11 (6%)
§103 only69 (39%)
§102 only12 (7%)
§112 only6 (3%)
Double-patenting only5 (3%)
Double-patenting + other18 (10%)
Multi-statute (no §101)49 (28%)
No statute on record1 (1%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

52
Life Sciences
29% of docket
30
Information Tech
17% of docket
29
Communications
16% of docket
4
Semiconductors
2% of docket
23
Mechanical / Eng
13% of docket
39
Business / Other
22% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,770 h
Manual time on pending OAs
354 h
Time saved (low, 20%)
620 h
Time saved (mid, 35%)
15.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HUDSON, AMY ROSE 5 74.9% +11.5%
TRAN, CHRISTINA L 3 51.6% +48.2%
WHITE, DAWANNA SHAR-DAY 2 62.5% +23.3%
RICCI, CRAIG D 2 53.5% +52.7%
KIFLE, BRUCK 2 79.2% +15.9%
SHAH, NILAY J 2 76.3% +46.9%
ZHU, QIN 2 87.4% +3.4%
GIBBS, TERRA C 2 63.7% +10.3%
YU, DELPHINUS DOU YI 2 33.3% +0.0%
POLIAKOVA-GEORGAN, EKATERINA 2 64.0% +18.0%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18265473 Apparatus, Methods and Computer Programs for Providing Spatial Audio ZHU, QIN 24d overdue
18654073 Rendering of Reverberation with Startup Control ZHU, QIN 9d

Hard Cases (66)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17221021 Core-Shell Particles and Composite Material Synthesized Therefrom CROWELL, ANNA M 100d overdue
17580279 Systems and Methods for Roof Area and Slope Estimation Using a Point Set DRAPEAU, SIMEON PAUL 60d overdue
18672139 Spatial Audio Parameter Merging ZHANG, LESHUI 59d overdue
18324191 METHODS AND COMPOSITIONS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION TRAN, CHRISTINA L 52d overdue
18317556 METHOD AND APPARATUS FOR FALLBACK HANDLING NGUYEN, STEVEN H D 36d overdue
18126224 SYSTEMS AND METHODS FOR CONTROLLING AND ENHANCING MOVEMENT OF A SURGICAL ROBOTIC UNIT DURING SURGERY CHIN, JAMES BRIAN 28d overdue
18571326 Apparatus, Methods and Computer Programs for Training Machine Learning Models JEREZ LORA, WILLIAM A 26d overdue
16250194 Method of Making a Ceramic Matrix Composite EMPIE, NATHAN H 25d overdue

Interview Candidates (20)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17683423 XANTHINE DEHYDROGENASE (XDH) iRNA COMPOSITIONS AND METHODS OF USE THEREOF HUDSON, AMY ROSE 110d overdue
18456718 IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE RICCI, CRAIG D 99d overdue
18324191 METHODS AND COMPOSITIONS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION TRAN, CHRISTINA L 52d overdue
18376217 TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF HUDSON, AMY ROSE 38d overdue
17974596 APOLIPOPROTEIN E (APOE) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF TRAN, CHRISTINA L 4d overdue
18302855 METHODS AND COMPOSITIONS FOR TREATING PRIMARY HYPEROXALURIA POLIAKOVA-GEORGAN, EKATERINA 14d
18852579 T-TYPE CALCIUM CHANNEL MODULATORS COMPRISING A PIPERAZINE OR 1,4-DIAZEPANE CORE AND METHODS OF USE THEREOF WHITE, DAWANNA SHAR-DAY —
18852396 T-TYPE CALCIUM CHANNEL MODULATORS COMPRISING A DIAZASPIROHEPTANE CORE AND METHODS OF USE THEREOF RICCI, CRAIG D —

Client Portfolio (37 clients)

Top Art Units

Art UnitApps
163710
16367
26915
26954
16353
24823
17973
37923
24662
26442

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19540291 HIGH STRENGTH SINGLE UNIT DOSE FORMULATIONS AND METHODS OF USE THEREOF Praxis Precision Medicines, Inc. SASAN, ARADHANA 1615 DP Final Rejection — Pending Feb 13, 2026
19361469 Generative Artificial Intelligence Systems and Methods for Processing Insurance Underwriting Data Insurance Services Office, Inc. SUBRAMANIAN, NARAYANSWAMY 3691 §101§103 Non-Final OA — Pending Oct 17, 2025
19469643 SYSTEMS AND METHODS FOR CONTROLLING ELASTIC CABLE DRIVEN ROBOT JOINTS Vicarious Surgical Inc. NGUYEN, ROBERT T 3619 §102§103§112 Non-Final OA — Pending Sep 26, 2025
19234365 Physical Downlink Control Channel Monitoring for Inter-Cell Beam Management Nokia Technologies Oy HAQUE, ABUSAYEED M 2466 §103 Non-Final OA — Pending Jun 11, 2025
19189968 Method, Apparatus and Computer Program Nokia Technologies Oy PHUONG, DAI 2644 §103DP Non-Final OA — Pending Apr 25, 2025
19075995 Material-Handling Robot With Magnetically Guided End-Effectors Persimmon Technologies Corporation KC, SAGAR §103 Non-Final OA — Pending Mar 11, 2025
19073878 Machine Learning Systems and Methods for Automatic Photo Labeling and Filing Xactware Solutions, Inc. LU, ZHIYU §102 Non-Final OA — Pending Mar 07, 2025
19066412 DYNAMIC CLAMPS AND METHODS OF USE THEREOF Praxis Precision Medicines, Inc. JACKSON-TONGUE, LAKIA J 1645 §102§112 Non-Final OA — Pending Feb 28, 2025
19062827 GENERATING GRAPHICAL REPRESENTATIONS FOR VIEWING 3D DATA AND/OR IMAGE DATA Faro Technologies, Inc. RICHER, AARON M 2617 §103 Final Rejection 44d overdue Pending Feb 25, 2025
19057507 MICROCHIP CAPILLARY ELECTROPHORESIS ASSAYS AND REAGENTS Regeneron Pharmaceuticals, Inc. BALL, JOHN C 1795 §103§112Other Non-Final OA — Pending Feb 19, 2025
19055929 Computer Vision Systems and Methods for Automatically Detecting, Classifying, and Pricing Objects Captured in Images or Videos Insurance Services Office, Inc. AKINYEMI, AJIBOLA A §102§103 Non-Final OA — Pending Feb 18, 2025
19036389 Machine Learning Systems and Methods for Automatic Construction Scheduling and Expense Estimation Xactware Solutions, Inc. DIVELBISS, MATTHEW H 3624 §101§102§103 Non-Final OA — Pending Jan 24, 2025
19009453 Compact Universal Gas Pool Heater And Associated Methods Hayward Industries, Inc. BAKER, LORI LYNN §101 Non-Final OA — Pending Jan 03, 2025
18879994 METHOD APPARATUS AND COMPUTER PROGRAM PRODUCT FOR SIGNALING BOUNDARY VERTICES Nokia Technologies Oy OAKES, JUSTIN MONTGOMERY §103 Non-Final OA — Pending Dec 30, 2024
18879038 REFERENCE AREA FOR INTRA PREDICTION Nokia Technologies Oy NIRJHAR, NASIM NAZRUL 2896 §103 Final Rejection 50d overdue AI Ready Dec 26, 2024
18978602 SNCA-TARGETING SIRNA COMPOSITIONS FOR TREATING SNCA-ASSOCIATED DISEASE Alnylam Pharmaceuticals, Inc. SULLIVAN, STEPHANIE LAUREN 1635 §103Other Non-Final OA 33d Pending Dec 12, 2024
18973911 Computer Vision Systems and Methods for Generating Building Models Using Three-Dimensional Sensing and Augmented Reality Techniques Insurance Services Office, Inc. WILSON, NICHOLAS R DP Non-Final OA — Pending Dec 09, 2024
18870953 SYSTEMS AND METHODS FOR STEREOSCOPIC VISUALIZATION IN SURGICAL ROBOTICS WITHOUT REQUIRING GLASSES OR HEADGEAR Vicarious Surgical Inc. ADAMS, EILEEN M §102§103§112 Non-Final OA — Pending Dec 02, 2024
18953486 Computer Vision Systems and Methods for Detecting Structures Using Aerial Imagery and Heightmap Data Insurance Services Office, Inc. COUSO, JOSE L §102§103 Non-Final OA — Pending Nov 20, 2024
18953925 HYDRODYNAMIC FOCUSING APPARATUS AND METHODS Cytonome/St, LLC CHAUDRY, ATIF H 3753 §103 Final Rejection 45d overdue Pending Nov 20, 2024
18864351 CRYSTALLINE POLYMORPHS OF N-METHYL-N-((1S,3S)-3-METHYL-3-((6-(1-METHYL-1H-PYRAZOL-4-YL)PYRAZOLO[1,5-A]PYRAZIN-4-YL)OXY)CYCLOBUTYL)ACRYLAMIDE BIOGEN MA INC. NEAGU, IRINA §102§112DP Non-Final OA — Pending Nov 08, 2024
18941023 MICROORGANISMS ENGINEERED TO REDUCE HYPERPHENYLALANINEMIA Synlogic Operating Company, Inc. GANGLE, BRIAN J §112DP Non-Final OA — Pending Nov 08, 2024
18864098 METHODS OF USE OF T-TYPE CALCIUM CHANNEL MODULATORS Praxis Precision Medicines, Inc. JACKSON, SHAWQUIA §102 Non-Final OA — Pending Nov 08, 2024
18930698 DERIVATION OF INTRA PREDICTION MODE MODES USING CONTENT ANALYSIS Nokia Technologies Oy HOLDER, ANNER N 2483 §102 Final Rejection — Pending Oct 29, 2024
18927451 TREATMENT OF NEUROLOGICAL DISORDERS Praxis Precision Medicines, Inc. VALENROD, YEVGENY 1628 §103DPOther Non-Final OA — Pending Oct 25, 2024
18913485 SYSTEMS AND METHODS FOR PATIENT TUMOR-IMMUNE PHENOTYPING FROM IMMUNOFLUORESCENCE (IF) IMAGE ANALYSIS Sanofi ZHENG, JACKY X §101 Non-Final OA — Pending Oct 11, 2024
18903563 MODIFICATION OF SPATIAL AUDIO SCENES Nokia Technologies Oy PATEL, YOGESHKUMAR G 2691 §102§103 Non-Final OA — Pending Oct 01, 2024
18852579 T-TYPE CALCIUM CHANNEL MODULATORS COMPRISING A PIPERAZINE OR 1,4-DIAZEPANE CORE AND METHODS OF USE THEREOF Praxis Precision Medicines, Inc. WHITE, DAWANNA SHAR-DAY §102§103§112 Non-Final OA — Pending Sep 30, 2024
18852396 T-TYPE CALCIUM CHANNEL MODULATORS COMPRISING A DIAZASPIROHEPTANE CORE AND METHODS OF USE THEREOF Praxis Precision Medicines, Inc. RICCI, CRAIG D §102§103 Non-Final OA — Pending Sep 27, 2024
18889677 CODING ADAPTATIONS FOR PIECE-WISE SMOOTH VIDEO CONTENT SUPPORTING BOTH GUIDED AND UNGUIDED BLOCK-WISE CODING Nokia Technologies Oy MESSMORE, JONATHAN R 2482 §102§103§112 Final Rejection — Pending Sep 19, 2024
18889534 INDICATION OF UE CAPABILITY USAGE Nokia Technologies Oy NGUYEN, THERESA §102Other Non-Final OA — Pending Sep 19, 2024
18888273 METHOD AND SYSTEM FOR INDEPENDENT PROOF-OF-CORRECT-SAMPLING OF STREAMING DATA Nokia Solutions and Networks Oy TOLENTINO, RODERICK 2439 §103 Final Rejection 30d AI Ready Sep 18, 2024
18882884 PYRUVATE KINASE ACTIVATORS FOR USE IN TREATING BLOOD DISORDERS Agios Pharmaceuticals, Inc. KIFLE, BRUCK DP Non-Final OA — Pending Sep 12, 2024
18845099 METHOD AND APPARATUS FOR TRANSMITTING FEEDBACK DURING WIRELESS COMMUNICATION Nokia Technologies Oy RAHMAN, SHAH M §102§103 Non-Final OA — Pending Sep 09, 2024
18826562 METHOD OF ASSEMBLING A LARGE VOLUME DELIVERY DEVICE Sanofi-Aventis Deutschland GmbH SHUTTY, DAVID G 3731 §103§112 Non-Final OA — Pending Sep 06, 2024
18817728 MULTI-CHANNEL RADIO TRANSCEIVER Nokia Technologies Oy TSE, YOUNG TOI 2632 §102§103§112 Final Rejection — Pending Aug 28, 2024
18816013 Multi-Cell Positioning Nokia Technologies Oy BATAILLE, FRANTZ §103 Non-Final OA — Pending Aug 27, 2024
18841428 Steel Wire and Spring with Excellent Antibacterial Properties and Corrosion Resistance and Method for Manufacturing the Same Scherdel Innotec Forschungs- Und Entwicklungs- GmbH KRUPICKA, ADAM C 1784 §103 Non-Final OA — Pending Aug 26, 2024
18841478 COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS Agios Pharmaceuticals, Inc. PIHONAK, SARAH §102 Non-Final OA — Pending Aug 26, 2024
18811440 Systems and Methods for Machine Learning From Medical Records Insurance Services Office, Inc. EZEWOKO, MICHAEL I §101§102§103 Non-Final OA — Pending Aug 21, 2024
18809785 Check Valve With Integral Handle Hayward Industries, Inc. TIETJEN, MARINA ANNETTE 3799 §102 Non-Final OA — Pending Aug 20, 2024
18809768 System and Method for Creating Customized Insurance-Related Forms Using Computing Devices Insurance Services Office, Inc. MERCADO VARGAS, ARIEL §103Other Non-Final OA — Pending Aug 20, 2024
18837245 EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF BIOGEN MA INC. WHITE, DAWANNA SHAR-DAY §112 Non-Final OA — Pending Aug 09, 2024
18791929 Machine Learning Systems and Methods for Image Splicing Detection and Localization Insurance Services Office, Inc. VANCHY JR, MICHAEL J 2666 §103 Non-Final OA — Pending Aug 01, 2024
18834785 DGK TARGETING COMPOUNDS AND USES THEREOF Arvinas Operations, Inc. SEAMAN, D MARGARET M §102§112 Non-Final OA — Pending Jul 31, 2024
18788444 Methods for NW-Sided Model Data Collection with Low Measurement Reporting Overhead Nokia Technologies Oy HAILEGIORGIS, FITWI Y 2632 §103 Non-Final OA 41d Pending Jul 30, 2024
18834466 METHODS OF TREATMENT USING T-TYPE CALCIUM CHANNEL MODULATORS Praxis Precision Medicines, Inc. LEE, CHIHYI NMN §103§112DP Non-Final OA — Pending Jul 30, 2024
18785324 Systems and Methods for Computerized Loss Scenario Modeling and Data Analytics Insurance Services Office, Inc. POINVIL, FRANTZY 3693 §101 Final Rejection 40d Pending Jul 26, 2024
18778334 MEASURING THE POSITION OF A MIRROR SURFACE IN POINT CLOUDS CAPTURED BY A SCANNER Faro Technologies, Inc. LEE, PAUL D §101 Non-Final OA — Pending Jul 19, 2024
18772763 ENHANCEMENT ON SIDELINK POSITIONING Nokia Technologies Oy ELNOUBI, SAID M §102§103 Final Rejection — Pending Jul 15, 2024
18761824 Spatial Augmentation Nokia Technologies Oy ZHENG, XUEMEI 2629 §102§103 Final Rejection — AI Ready Jul 02, 2024
18761504 COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE Alnylam Pharmaceuticals, Inc. ZAHORIK, AMANDA MARY §102§103§112 Non-Final OA — Pending Jul 02, 2024
18753268 Universal Mount For A Variable Speed Pump Drive User Interface Hayward Industries, Inc. COMLEY, ALEXANDER BRYANT 3746 §112Other Final Rejection 53d Pending Jun 25, 2024
18746428 FORMULATIONS OF T-TYPE CALCIUM CHANNEL MODULATORS AND METHODS OF USE THEREOF Praxis Precision Medicines, Inc. CHANDRAKUMAR, NIZAL S 1625 — Non-Final OA — Pending Jun 18, 2024
18718253 Apparatus, Methods and Computer Programs for Generating Spatial Audio Output Nokia Technologies Oy PAUL, DISLER 2695 §102§103 Non-Final OA — Pending Jun 10, 2024
18732311 Valve and Method Getinge Aseptic Solutions, LLC HICKS, ANGELISA 3753 §112 Non-Final OA — Pending Jun 03, 2024
18672139 Spatial Audio Parameter Merging Nokia Technologies Oy ZHANG, LESHUI 2695 §103§112 Final Rejection 59d overdue AI Ready May 23, 2024
18671531 MEDICAL DEVICE AND METHOD FOR LIMITING THE USE OF THE MEDICAL DEVICE Sanofi-Aventis Deutschland GmbH SHAH, NILAY J §103Other Non-Final OA — Pending May 22, 2024
18669105 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES Arvinas Operations, Inc. KIFLE, BRUCK 1624 §102§103§112DP Non-Final OA — Pending May 20, 2024
18667975 Systems and Methods for Passive and Active Hybrid Defrost Control for Pool/Spa Heat Pumps Hayward Industries, Inc. SHAIKH, MERAJ A 3763 §103 Non-Final OA 33d Pending May 17, 2024
18710130 BRM DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE Genentech, Inc. MCKOY, QUINCY ANDRE §102§112 Non-Final OA — Pending May 14, 2024
18661199 SEALING ARRANGEMENT FOR SYRINGE AbbVie Inc. SHAH, NILAY J §101§103 Non-Final OA — Pending May 10, 2024
18654073 Rendering of Reverberation with Startup Control Nokia Technologies Oy ZHU, QIN 2691 DP Non-Final OA 9d AI Ready May 03, 2024
18637055 CONCENTRATION-DEPENDENT SELF-INTERACTION ASSAY Regeneron Pharmaceuticals, Inc. NGUYEN, NAM P §102§103§112 Non-Final OA — Pending Apr 16, 2024
18632564 IMAGE ACQUISITION FOR THREE-DIMENSIONAL (3D) COORDINATE MEASUREMENT DEVICES Faro Technologies, Inc. TRAN, PHUOC 2668 §103 Non-Final OA — Pending Apr 11, 2024
18623722 EGFR PROTEOLYSIS TARGETING CHIMERIC MOLECULES AND ASSOCIATED METHODS OF USE Yale University DAHLIN, HEATHER RAQUEL 1629 §103§112Other Non-Final OA 53d Pending Apr 01, 2024
18623281 RENAL INJURY BIOMARKERS AS BIOMARKERS FOR ACUTE HEPATIC PORPHYRIA (AHP) Alnylam Pharmaceuticals, Inc. BRETZ, COREY LANE §102§103§112DP Non-Final OA — Pending Apr 01, 2024
18695611 METHOD, APPARATUS AND COMPUTER PROGRAM PRODUCT FOR IMPLEMENTING MECHANISMS FOR CARRIAGE OF RENDERABLE TEXT Nokia Technologies Oy SHELEHEDA, JAMES R 2424 §102§103§112 Non-Final OA — Pending Mar 26, 2024
18693380 AN APPARATUS, A METHOD AND A COMPUTER PROGRAM FOR VIDEO CODING AND DECODING Nokia Technologies Oy KWAN, MATTHEW K 2482 §103 Non-Final OA — Pending Mar 19, 2024
18692541 DIROXIMEL FUMARATE PARTICLES HAVING IMPROVED FLOW PROPERTIES AND METHODS OF MAKING SAME BIOGEN MA INC. JARRELL, NOBLE E 1699 §102 Non-Final OA — Pending Mar 15, 2024
18588932 Systems and Methods for Modeling Structures Using Point Clouds Derived from Stereoscopic Image Pairs Insurance Services Office, Inc. MEROUAN, ABDERRAHIM 2683 §103Other Final Rejection — Pending Feb 27, 2024
18587232 Three-Dimensional-Flux Electric Motor And Method For Making Thereof Persimmon Technologies Corporation VO, ETHAN NGUYEN 2834 §103 Final Rejection 4d overdue Pending Feb 26, 2024
18581511 BETA-CATENIN (CTNNB1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Alnylam Pharmaceuticals, Inc. VYAS, KEYUR ANILKUMAR 1637 §103Other Non-Final OA 79d Pending Feb 20, 2024
18682863 METHOD UE INDICATION OF PRS MEASUREMENT MODE Nokia Technologies Oy BARRY, JUSTIN ARTHUR 2643 §102§103 Non-Final OA 5d AI Ready Feb 09, 2024
18434928 COMPOSITIONS AND METHODS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION Alnylam Pharmaceuticals, Inc. HUDSON, AMY ROSE 1636 §103 Final Rejection — Pending Feb 07, 2024
18423377 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE (HMGCR) IRNA COMPOSITIONS AND METHODS OF USE THEREOF Alnylam Pharmaceuticals, Inc. GROOMS, TIFFANY NICOLE §101§103§112 Non-Final OA — Pending Jan 26, 2024
18292747 TREATMENT OF HFPEF IN POST-MENOPAUSAL WOMEN WITH AN SGC STIMULATOR Cyclerion Therapeutics, Inc. YOO, SUN JAE 1621 §103 Non-Final OA — Pending Jan 26, 2024
18412677 Acoustic Echo Cancellation Nokia Technologies Oy ROBERTS, SHAUN A 2655 §102§103 Non-Final OA 22d overdue Pending Jan 15, 2024
18578341 LTBP COMPLEX-SPECIFIC INHIBITORS OF TGFb1 AND USES THEREOF Scholar Rock, Inc. FAUST, AMBER KATHLEEN §102§103§112DP Non-Final OA — Pending Jan 11, 2024
18576933 COMPOUNDS FOR TARGETING DEGRADATION OF IRAK4 PROTEINS C4 Therapeutics, Inc. HASTINGS, ALISON AZAR 1627 §103 Final Rejection — Pending Jan 05, 2024
18403862 METHODS AND COMPOSITIONS FOR TREATING SUBJECTS HAVING OR AT RISK OF DEVELOPING A NON-PRIMARY HYPEROXALURIA DISEASE OR DISORDER Alnylam Pharmaceuticals, Inc. WHITEMAN, BRIAN A §102§103§112DP Non-Final OA — Pending Jan 04, 2024
18575419 A Radio Receiver with an Iterative Neural Network, and Related Methods and Computer Programs Nokia Solutions and Networks Oy LEE, SANG CHEON 2467 §103 Final Rejection 31d overdue AI Ready Dec 29, 2023
18574918 Creating Spatial Audio Stream from Audio Objects with Spatial Extent Nokia Technologies Oy OPSASNICK, MICHAEL N 2658 §103 Non-Final OA — Pending Dec 28, 2023
18574899 Link Adaptation Nokia Technologies Oy KNAPP, JUSTIN R 2112 §101 Final Rejection — AI Ready Dec 28, 2023
18572100 METHOD, APPARATUS AND COMPUTER PROGRAM PRODUCT FOR PROVIDING AN ATTENTION BLOCK FOR NEURAL NETWORK-BASED IMAGE AND VIDEO COMPRESSION Nokia Technologies Oy LEE, TSU-CHANG §112 Non-Final OA — Pending Dec 19, 2023
18571326 Apparatus, Methods and Computer Programs for Training Machine Learning Models Nokia Technologies Oy JEREZ LORA, WILLIAM A 2695 §103§112 Final Rejection 26d overdue AI Ready Dec 18, 2023
18542950 METHODS AND COMPOSITIONS FOR TREATING AN ANGIOTENSINOGEN- (AGT-) ASSOCIATED DISORDER Alnylam Pharmaceuticals, Inc. GIBBS, TERRA C §103§112DP Non-Final OA — Pending Dec 18, 2023
18542549 Systems And Methods For Smart Valve Control Of Pool And Spa Components And Operations Hayward Industries, Inc. SKUBINNA, CHRISTINE J 3754 §102 Final Rejection 23d overdue Pending Dec 15, 2023
18571090 SYNTHETIC PREPARATION FOR DIROXIMEL FUMARATE BIOGEN MA INC. SANCHEZ, JUSTIN CHRISTOPHER 1622 §103§112 Non-Final OA — Pending Dec 15, 2023
18567736 METHOD, APPARATUS AND COMPUTER PROGRAM PRODUCT FOR DEFINING IMPORTANCE MASK AND IMPORTANCE ORDERING LIST Nokia Technologies Oy STORK, KYLE R §101§102§103 Non-Final OA — Pending Dec 06, 2023
18566747 Livestock Excrement Sterilizing and Drying System Using High Temperature Combustion Gas, and Sterilizing and Drying Method Ntnecotech Co., Ltd. GIORDANO, MICHAEL JAMES 1731 §103§112 Non-Final OA — Pending Dec 04, 2023
18525922 PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Alnylam Pharmaceuticals, Inc. YU, DELPHINUS DOU YI §101§102§103 Non-Final OA — Pending Dec 01, 2023
18517225 Computer Vision Systems and Methods for Information Extraction from Floorplan Images Insurance Services Office, Inc. COBB, MICHAEL J 2615 §103 Final Rejection 43d overdue Pending Nov 22, 2023
18389375 METHODS FOR DETECTING AND EVALUATING VIRUSES AND VIRUS-LIKE PARTICLES Regeneron Pharmaceuticals, Inc. WHITE, DENNIS MICHAEL 2877 §102§103 Non-Final OA — Pending Nov 14, 2023
18389245 SODIUM-GLUCOSE COTRANSPORTER-2 (SGLT2) IRNA COMPOSITIONS AND METHODS OF USE THEREOF Alnylam Pharmaceuticals, Inc. ZARA, JANE J 1637 §101§103 Non-Final OA — Pending Nov 14, 2023
18560430 METHOD, APPARATUS AND COMPUTER PROGRAM PRODUCT FOR PROVIDING FINETUNED NEURAL NETWORK Nokia Technologies Oy ALAVI, AMIR 2668 §103 Non-Final OA 56d Pending Nov 13, 2023
18288888 METHODS FOR TITRATING MITAPIVAT Agios Pharmaceuticals, Inc. RZECZYCKI, PHILLIP MATTHEW 1625 §103 Final Rejection 22d Pending Oct 30, 2023
18384159 Modular Pool/Spa Control System Hayward Industries, Inc. LIN, JASON 2117 §103 Final Rejection 59d overdue Pending Oct 26, 2023
18493412 RAPID, MICROFLUIDIC DIAGNOSTIC DEVICE AND METHOD FOR BIOLOGICAL SEX DETERMINATION Definitive Biotechnologies LLC ALABI, OYELEYE A 1797 §102§103 Non-Final OA — Pending Oct 24, 2023
18287616 TREATMENT OF CNS DISEASES WITH sGC STIMULATORS Tisento Therapeutics Inc. WEDDINGTON, KEVIN E 1629 §112 Final Rejection — Pending Oct 19, 2023
18376217 TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF Alnylam Pharmaceuticals, Inc. HUDSON, AMY ROSE 1636 §112DP Non-Final OA 38d overdue Pending Oct 03, 2023
18553690 POSITIONING ENHANCEMENT MECHANISM Nokia Technologies Oy MANOHARAN, MUTHUSWAMY GANAPATHY 2647 §103 Non-Final OA — Pending Oct 02, 2023
18373397 PROLINE DEHYDROGENASE 2 (PRODH2) IRNA COMPOSITIONS AND METHODS OF USE THEREOF Alnylam Pharmaceuticals, Inc. POLIAKOVA-GEORGAN, EKATERINA 1637 §103 Non-Final OA — Pending Sep 27, 2023
18373344 Apparatus, Method and Computer Program Nokia Technologies Oy CHOI, WON JUN 2411 §102§103 Final Rejection 15d AI Ready Sep 27, 2023
18552783 MECHANISM FOR DELIVERING BEAM INFORMATION Nokia Technologies Oy PHAM, TITO Q 2466 §103 Non-Final OA — Pending Sep 27, 2023
18283493 Interactive Audio Rendering of a Spatial Stream Nokia Technologies Oy KRZYSTAN, ALEXANDER J 2694 §102 Final Rejection 111d overdue AI Ready Sep 22, 2023
18551100 GENERAL REGION-BASED HASH Nokia Technologies Oy HASAN, MAINUL 2485 §103 Non-Final OA 19d overdue AI Ready Sep 18, 2023
18367222 Apparatus, Methods, and Computer Programs Nokia Solutions and Networks Oy WELTE, BENJAMIN PETER 2477 §102§103 Non-Final OA 8d overdue AI Ready Sep 12, 2023
18243133 GLYCOGEN SYNTHASE KINASE 3 ALPHA (GSK3 ALPHA) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Alnylam Pharmaceuticals, Inc. TRAN, CHRISTINA L 1637 §101§103§112 Non-Final OA — Pending Sep 07, 2023
18548634 DOSING OF siRNA COMPOUNDS TO THE CISTERNA MAGNA Alnylam Pharmaceuticals, Inc. HUDSON, AMY ROSE 1636 §102§103§112 Non-Final OA — Pending Sep 01, 2023
18456718 IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE Arvinas Operations, Inc. RICCI, CRAIG D 1611 §103 Final Rejection 99d overdue Pending Aug 28, 2023
18236437 PRION PROTEIN (PRNP) IRNA COMPOSITIONS AND METHODS OF USE THEREOF Alnylam Pharmaceuticals, Inc. YU, DELPHINUS DOU YI 1636 §103DP Non-Final OA — Pending Aug 22, 2023
18226872 Determining Spatial Audio Parameters Nokia Technologies Oy HUBER, PAUL W 2691 §102 Non-Final OA 61d Pending Jul 27, 2023
18221934 ISOELECTRIC FOCUSING-BASED ENRICHMENT OF CHARGE VARIANT SPECIES Regeneron Pharmaceuticals, Inc. FRITCHMAN, REBECCA M 1758 §103 Non-Final OA — Pending Jul 14, 2023
18261342 ENABLING EARLY PDCCH ORDER FOR PUCCH SCELL ACTIVATION Nokia Technologies Oy VU, HUY DUY 2461 §103 Non-Final OA — Pending Jul 13, 2023
18219924 Re-Establishment of Component Carriers in a Wireless Communication System Nokia Technologies Oy BEDNASH, JOSEPH A 2461 §102 Final Rejection 69d AI Ready Jul 10, 2023
18347834 BACKWARD COMPATIBLE CARRIAGE OF CODED UNITS FROM DIFFERENT CODECS Nokia Technologies Oy GLOVER, CHRISTOPHER KINGSBURY 2485 §103 Non-Final OA — AI Ready Jul 06, 2023
18346143 ARITHMETIC CODING WITH SPATIAL TUNING Nokia Technologies Oy RETALLICK, KAITLIN A 2482 §103 Final Rejection 19d AI Ready Jun 30, 2023
18217355 Extruded Reinforced Industrial Belt Albany International Corp. STEELE, JENNIFER A 1789 §102§103§112 Non-Final OA — Pending Jun 30, 2023
18215849 COMPLEMENT COMPONENT 9 (C9) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Alnylam Pharmaceuticals, Inc. GIBBS, TERRA C 1635 §101 Non-Final OA — Pending Jun 29, 2023
18213011 SYSTEM AND METHOD FOR IMPLEMENTING A MULTI-TURN ROTARY CONCEPT IN AN ACTUATOR MECHANISM OF A SURGICAL ROBOTIC ARM Vicarious Surgical Inc. HUSSAINI, ATTIYA SAYYADA 3792 §103 Final Rejection — Pending Jun 22, 2023
18267130 Method for Depositing a Bronze Alloy on a Printed Circuit and Printed Circuit Obtained by Said Method Linxens Holding WITTENBERG, STEFANIE S 1795 §103 Final Rejection 85d overdue Pending Jun 14, 2023
18334758 APPARATUS, METHOD AND COMPUTER PROGRAM PRODUCT FOR QUANTIZING NEURAL NETWORKS Nokia Technologies Oy BECK, LERON 2487 §103 Final Rejection 4d overdue AI Ready Jun 14, 2023
18207406 Speech Enhancement Nokia Technologies Oy BLANKENAGEL, BRYAN S 2658 §103 Non-Final OA 15d AI Ready Jun 08, 2023
18265473 Apparatus, Methods and Computer Programs for Providing Spatial Audio Nokia Technologies Oy ZHU, QIN 2691 §102 Final Rejection 24d overdue AI Ready Jun 06, 2023
18324191 METHODS AND COMPOSITIONS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION Alnylam Pharmaceuticals, Inc. TRAN, CHRISTINA L 1637 §103§112Other Final Rejection 52d overdue Pending May 26, 2023
18197579 BIOANALYSIS OF THERAPEUTIC ANTIBODIES AND RELATED PRODUCTS USING IMMUNOPRECIPITATION AND NATIVE SEC-PCD-MS DETECTION Regeneron Pharmaceuticals, Inc. SPANGLER, JOSEPH RANKIN 1656 §103§112Other Non-Final OA — Pending May 15, 2023
18317556 METHOD AND APPARATUS FOR FALLBACK HANDLING Nokia Technologies Oy NGUYEN, STEVEN H D 2414 §101§103 Final Rejection 36d overdue AI Ready May 15, 2023
18138457 METHOD FOR EVALUATING ACTION IMPACT OVER MOBILE NETWORK PERFORMANCE Nokia Solutions and Networks Oy NAWAZ, ASAD M 2463 §103 Final Rejection 15d AI Ready Apr 24, 2023
18032843 Pre-Processing in Uplink RAN Using Neural Network Institut Mines-Télécom ANDERSON, MARGARET MARIE 2412 §103 Final Rejection 111d overdue Pending Apr 20, 2023
18302855 METHODS AND COMPOSITIONS FOR TREATING PRIMARY HYPEROXALURIA Alnylam Pharmaceuticals, Inc. POLIAKOVA-GEORGAN, EKATERINA 1637 §102§103§112DP Final Rejection 14d Pending Apr 19, 2023
18136386 MUCIN 5B (MUC5B) IRNA COMPOSITIONS AND METHODS OF USE THEREOF Alnylam Pharmaceuticals, Inc. HUDSON, AMY ROSE 1636 §102§103§112 Non-Final OA — Pending Apr 19, 2023
18301089 PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Alnylam Pharmaceuticals, Inc. CHONG, KIMBERLY 1636 §103§112DP Final Rejection 127d overdue Pending Apr 14, 2023
18031371 TREATMENT OF COGNITIVE IMPAIRMENT WITH A CNS-PENETRANT sGC STIMULATOR Tisento Therapeutics Inc. FETTEROLF, BRANDON J 1626 DPOther Final Rejection 70d Pending Apr 12, 2023
18031524 BOX FOR A MEDICAMENT PACKAGING ASSEMBLY Sanofi SKURDAL, COREY NELSON 3734 §103 Final Rejection — Pending Apr 12, 2023
18131892 SUPEROXIDE DISMUTASE 1 (SOD1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING SUPEROXIDE DISMUTASE 1- (SOD1-) ASSOCIATED NEURODEGENERATIVE DISEASES Alnylam Pharmaceuticals, Inc. ANGELL, JON E 1637 §102§103 Non-Final OA — Pending Apr 07, 2023
18129923 G PROTEIN-COUPLED RECEPTOR 75 (GPR75) IRNA COMPOSITIONS AND METHODS OF USE THEREOF Regeneron Pharmaceuticals, Inc. MEYERING, SHABANA SHABBEER 1635 §102§103 Non-Final OA 62d Pending Apr 03, 2023
18127918 Systems And Methods For Data Transfer And Platform Integration Using Quick Response (QR) Codes Xactware Solutions, Inc. TARDIF, DAVID P 2876 §103 Non-Final OA — Pending Mar 29, 2023
18126224 SYSTEMS AND METHODS FOR CONTROLLING AND ENHANCING MOVEMENT OF A SURGICAL ROBOTIC UNIT DURING SURGERY Vicarious Surgical Inc. CHIN, JAMES BRIAN 3656 §102§103§112 Final Rejection 28d overdue Pending Mar 24, 2023
18028058 PHARMACEUTICAL FORMULATION Agios Pharmaceuticals, Inc. LEE, SIN J 1613 §103§112 Non-Final OA — Pending Mar 23, 2023
18121796 Adaptive Filtering of Occupancy Map for Dynamic Mesh Compression Nokia Technologies Oy SHIFERAW, HENOK ASRES 2676 §103 Final Rejection 157d overdue AI Ready Mar 15, 2023
18112566 Method for Determining Mutual Coupling Nokia Solutions and Networks Oy RIDDER, CLAYTON PAUL 3646 §103 Non-Final OA 124d overdue Pending Feb 22, 2023
18021643 METHODS FOR TREATING REMITTING MULTIPLE SCLEROSIS BIOGEN MA INC. CORNET, JEAN P 1628 §103Other Non-Final OA 49d overdue Pending Feb 16, 2023
18109528 Enhancement of Packet Based Voice Call Service Over Satellite Link Nokia Solutions and Networks Oy KELLEY, STEVEN SHAUN 2644 §103 Non-Final OA 69d Pending Feb 14, 2023
18095315 SYSTEM AND METHOD FOR REVERSING ORIENTATION AND VIEW OF SELECTED COMPONENTS OF A MINIATURIZED SURGICAL ROBOTIC UNIT IN VIVO Vicarious Surgical Inc. WEBSTER, KARMEL JOHANNA 3792 §103 Final Rejection — Pending Jan 10, 2023
18090983 ROTATIONAL ACTUATORS FOR SURGICAL ROBOTIC SYSTEMS Vicarious Surgical Inc. WEBSTER, KARMEL JOHANNA 3792 §103 Non-Final OA — Pending Dec 29, 2022
18086880 Systems and Methods for Providing Network Connectivity and Remote Monitoring, Optimization, and Control of Pool/Spa Equipment Hayward Industries, Inc. ERDMAN, CHAD G 2116 §103 Final Rejection — Pending Dec 22, 2022
18086904 Systems and Methods for Providing Network Connectivity and Remote Monitoring, Optimization, and Control of Pool/Spa Equipment Hayward Industries, Inc. ERDMAN, CHAD G 2116 §102§103 Non-Final OA 28d Pending Dec 22, 2022
18076872 Spatial Audio Object Positional Distribution within Spatial Audio Communication Systems Nokia Technologies Oy BEKEE, CHIMEZIE EZERIWE 2691 §103 Non-Final OA 28d AI Ready Dec 07, 2022
17974596 APOLIPOPROTEIN E (APOE) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF Alnylam Pharmaceuticals, Inc. TRAN, CHRISTINA L 1637 §103 Final Rejection 4d overdue Pending Oct 27, 2022
17972096 Radio Configuration Parameter Optimization by Using a Dual Control Algorithm Nokia Solutions and Networks Oy ABBATINE JR., MICHAEL WILLIAM 2419 §103 Final Rejection 16d overdue AI Ready Oct 24, 2022
17919310 Apparatus, Methods and Computer Programs for Enabling Rendering of Spatial Audio Signals Nokia Technologies Oy KANG, ANNABELLE 2695 §102§103 Non-Final OA — Pending Oct 17, 2022
17917988 METHOD AND SYSTEM OF PRODUCING HYDROGEL MICROSPHERES Hifibio (Hk) Limited HEINCER, LIAM J 1767 §103 Non-Final OA 19d overdue Pending Oct 10, 2022
17899331 Systems and Methods for Computer Modeling Using Incomplete Data Insurance Services Office, Inc. CORRIELUS, JEAN M 2159 §103 Non-Final OA — Pending Aug 30, 2022
17889530 Method, An Apparatus and A Computer Program Product for Video Encoding and Video Decoding Nokia Technologies Oy CHANG, DANIEL 2487 §103 Non-Final OA — Pending Aug 17, 2022
17886279 PEN-TYPE DRUG INJECTION DEVICE WITH CONTROLLER AND TIME LOCK-OUT MECHANISM FOR ITS DRIVE Sanofi-Aventis Deutschland GmbH FARRAR, LAUREN PENG 3783 §103§112 Final Rejection 14d Pending Aug 11, 2022
17870368 NATIVE MICROFLUIDIC CE-MS ANALYSIS OF ANTIBODY CHARGE HETEROGENEITY Regeneron Pharmaceuticals, Inc. XU, XIAOYUN 1797 §103Other Final Rejection 55d Pending Jul 21, 2022
17782933 METHOD AND APPARATUS FOR ENCODING/DECODING IMAGE ON BASIS OF PICTURE HEADER INCLUDING INFORMATION RELATING TO CO-LOCATED PICTURE, AND METHOD FOR TRANSMITTING BITSTREAM Nokia Technologies Oy LOTFI, KYLE M 2425 §103 Final Rejection 46d overdue AI Ready Jun 06, 2022
17826120 SYSTEMS AND METHODS FOR CONTROLLING A SURGICAL ROBOTIC ASSEMBLY IN AN INTERNAL BODY CAVITY Vicarious Surgical Inc. LE, KHOA TAN 3771 §103 Final Rejection 32d overdue Pending May 26, 2022
17779865 METHODS OF USING SOLUBLE SOLID DISPERSIONS OF RIFAXIMIN The United States Department of Veterans Affairs MEYERS, ELIZABETH ANNE 1617 §103 Non-Final OA 13d Pending May 25, 2022
17717729 Compression Framework for Distributed or Federated Learning with Predictive Compression Paradigm Nokia Technologies Oy GORMLEY, AARON PATRICK 2148 §103 Non-Final OA 33d Pending Apr 11, 2022
17697462 MICROFLUIDIC ASSEMBLY FOR SURFACE ACOUSTIC WAVE PARTICLE MANIPULATION Cytonome/St, LLC GERHARD, ALISON CLAIRE 1797 §103 Final Rejection — Pending Mar 17, 2022
17683423 XANTHINE DEHYDROGENASE (XDH) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Alnylam Pharmaceuticals, Inc. HUDSON, AMY ROSE 1636 §112DP Final Rejection 110d overdue Pending Mar 01, 2022
17668413 SMALL RIBOSOMAL PROTEIN SUBUNIT 25 (RPS25) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF Alnylam Pharmaceuticals, Inc. ALLEN, SARAH ELIZABETH 1637 §102§103§112 Final Rejection — Pending Feb 10, 2022
17580279 Systems and Methods for Roof Area and Slope Estimation Using a Point Set Insurance Services Office, Inc. DRAPEAU, SIMEON PAUL 2188 §101§103§112 Non-Final OA 60d overdue Pending Jan 20, 2022
17597603 MASA with Embedded Near-Far Stereo for Mobile Devices Nokia Technplogies OY BOGGS JR., JAMES 2657 §103 Non-Final OA — Pending Jan 13, 2022
17619633 DELIVERY OF OLIGONUCLEOTIDES TO THE STRIATUM Alnylam Pharmaceuticals, Inc. MCKILLOP, JOHN CHARLES 1637 §112DP Final Rejection — Pending Dec 16, 2021
17644372 TASK-DEPENDENT SELECTION OF DECODER-SIDE NEURAL NETWORK Nokia Technologies Oy BOSTWICK, SIDNEY VINCENT 2124 §103§112 Non-Final OA — Pending Dec 15, 2021
17456516 IMAGING MARKER AND METHOD Beekley Corporation BUI PHO, PASCAL M 3798 §103 Non-Final OA 30d overdue Pending Nov 24, 2021
17456508 IMAGING MARKER AND METHOD Beekley Corporation RAYMOND, KEITH MICHAEL 3798 §103§112DP Final Rejection 43d overdue Pending Nov 24, 2021
17528234 HIGH DENSITY LIPOPROTEIN BINDING PROTEIN (HDLBP/VIGILIN) iRNA COMPOSITIONS AND METHODS OF USE THEREOF ETH ZÜRICH VIVLEMORE, TRACY ANN 1638 DP Final Rejection — Pending Nov 17, 2021
17355995 Systems and Methods for Generating Property Data Packages from Lidar Point Clouds Insurance Services Office, Inc. YANG, ANDREW GUS 2614 §103 Non-Final OA — Pending Jun 23, 2021
17221021 Core-Shell Particles and Composite Material Synthesized Therefrom Persimmon Technologies Corporation CROWELL, ANNA M 1716 §102§103 Non-Final OA 100d overdue Pending Apr 02, 2021
17056846 CHILD DETERRENT ZIPPER CLOSURE (as amended) Illinois Tool Works Inc. BATTISTI, DEREK J 3734 §112 Final Rejection — Pending Nov 19, 2020
17001884 Robot Linear Drive Heat Transfer Persimmon Technologies Corporation TIGHE, BRENDAN P 3652 §103 Final Rejection — Pending Aug 25, 2020
16250194 Method of Making a Ceramic Matrix Composite Albany Engineered Composites, Inc. EMPIE, NATHAN H 1712 §103§112 Non-Final OA 25d overdue Pending Jan 17, 2019
15766586 STABLE PROTEIN COMPOSITIONS Regeneron Pharmaceuticals, Inc. SAEED, ALI S 1616 §103§112 Non-Final OA 83d Pending Apr 06, 2018

Managing Mccarter & English, LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month